The terminal step in the apoptotic program is the removal of dying cells by phagocytes. Apoptotic cell clearance, an evolutionarily conserved process, is performed by tissueresident neighboring cells or by "professional" phagocytes such as macrophages and dendritic cells. Receptors on the phagocyte recognize specific surface markers ("eat-me" signals) expressed by apoptotic cells. This recognition results in signals that lead to reorganization of the phagocytic cell's cytoskeleton to enable engulfment and degradation of the dying cell. A number of receptors that mediate engulfment of apoptotic cells have been identified in Caenorhabditis elegans, Drosophila, and mammalian cells (Ravichandran and Lorenz, 2007) . The multiple receptors and ligands involved demonstrate the complexity of apoptotic cell engulfment and the need to further define the signaling pathways of this fundamental process.
In this issue of Cell, Kurant et al. (2008) report that glial cells in the developing central nervous system (CNS) of Drosophila efficiently engulf apoptotic neurons using an engulfment receptor, which they call six-micronsunder, or SIMU (Figure 1 ). At the end of embryonic development, an epithelial barrier ensheathes the ventral nerve cord, and macrophages are excluded. However, the authors show that dying neurons can be efficiently captured and cleared by sessile glial cells that remain in the CNS with little requirement for macrophages; similar bystander engulfment in the CNS has been reported by others (Freeman et al., 2003; Sonnenfeld and Jacobs, 1995) . The authors used gene expression profiling of isolated glia from the fly CNS to identify genes involved in the engulfment of apoptotic cells. They identified a new transmembrane protein, SIMU, that is strongly expressed on the surface of glial cells and macrophages and that is upregulated during major waves of developmental apoptosis. In vivo, SIMU-deficient glia show a decreased ability in contacting and engulfing apoptotic cells. An attendant increase in the number of unengulfed apoptotic cells in the CNS is also observed in fly embryos harboring these SIMU-deficient glia, thus pointing to a role for SIMU in the recognition of apoptotic neurons. In vitro, purified SIMU can bind to apoptotic but not viable S2 cultured insect cells, indicating that the extracellular portion of SIMU recognizes a specific, as-yet-unidentified moiety on apoptotic cells. Shown are two transmembrane proteins SIMU and Draper with multiple extracellular EGF-like NIMROD repeats (blue) and an EMILIN-like (EMI) proteininteraction domain (green). The newly identified glial cell transmembrane protein SIMU tethers apoptotic neurons enabling efficient phagocytic clearance in the developing Drosophila CNS (Kurant et al., 2008) . SIMU is in the same pathway as Draper and appears to function upstream of it. Draper is important for corpse recognition and may also be involved in corpse degradation. Draper may recognize apoptotic cells through the binding of an unknown ligand (Y) and internalization via the cytoplasmic adaptor protein dCED-6. How SIMU communicates with Draper is not known, but one possibility is that the EMI domains of the two proteins play a role in this process (blue arrows). As SIMU appears to be involved in the initial recognition and uptake steps of engulfment but lacks an intracellular signaling domain, it is possible that SIMU interacts with another engulfment receptor (green) to transmit signals necessary for cytoskeletal rearrangements and corpse internalization via ligand X.
Death in the CNS
The simu gene was originally identified as ORF CG16876 within a cluster of 10 nimrod genes on Drosophila chromosome 2 (Kocks et al., 2005; Kurucz et al., 2007) . It is predicted to encode a 377 amino acid type I transmembrane protein possessing a short cytoplasmic tail, a transmembrane domain, and an extracellular portion containing four NIMROD-type EGF repeats and an EMILIN-like domain. The simu gene is a member of the recently identified nimrod family of genes, some of which encode proteins that are involved in the uptake of bacteria (Kocks et al., 2005; Kurucz et al., 2007) . NIMROD proteinswhich may be membrane anchored or secreted depending on the presence of the transmembrane domain-are characterized by a number of conserved cysteine-rich EGF-like repeats (called NIM repeats) separated by variable loops of 6-11 residues (Kurucz et al., 2007) . Transmembrane NIMROD proteins usually possess a short cytoplasmic tail devoid of known protein interaction motifs, suggesting a lack of ability to directly signal intracellularly. Two other engulfment receptors, CED-1 in C. elegans and Draper in Drosophila, display similar domain arrangements to NIMROD proteins, including a number of tandem EGF-like extracellular domains, with the primary difference being that these proteins have longer cytoplasmic tails that serve as docking sites for signaling proteins (Awasaki et al., 2006) . Interestingly, NIMROD-like features are also found in the mammalian engulfment proteins MEGF10 and Jedi, raising the possibility that NIM-ROD proteins play an evolutionarily conserved role in engulfment.
Intriguingly, Kurant et al. find that SIMU appears to function upstream of the engulfment protein Draper ( Figure  1 ). Draper is expressed on the surface of glia and macrophages and is required for the engulfment of apoptotic neurons and degenerating axons in the fly CNS (Awasaki et al., 2006; Freeman et al., 2003; MacDonald et al., 2006) . How SIMU might cooperate with Draper during engulfment remains unclear. As Kurant et al. were unable to detect a physical association between SIMU and Draper, it seems likely that other factors are required to connect these proteins. The authors make an intriguing observation that may provide a clue. In genetic rescue experiments of mutant flies expressing different forms of simu, the investigators find that the extracellular EMI domain of SIMU is essential for optimal apoptotic cell clearance. Surprisingly, a soluble, secreted mutant form of SIMU lacking the transmembrane domain (SIMU∆TM) could also promote engulfment in these rescue studies. Given that SIMU is normally expressed on the phagocyte cell surface, this soluble mutant form (carrying the EMI domain required for recognition of apoptotic cells) is expected to interfere with recognition. One explanation for this unexpected observation is that the EMI domains are somehow involved in homotypic adhesion or oligomerization between EMI domain-containing proteins (Figure 1 ). If this is the case, the SIMU∆TM mutant could represent a "gain-of-function" mutation that binds to and activates other EMI-domain proteins and thereby promotes apoptotic cell clearance. As the stoichiometry of SIMU∆TM is not known, it is possible that the SIMU∆TM itself may be an oligomer and could help to bridge an apoptotic cell marker and another EMI-domain receptor such as Draper. Although the authors state that no apparent interactions between SIMU and Draper were found, it is unclear how this was tested and whether the isolated EMI domains of the two proteins were examined. Future experiments should be able to directly test this possibility.
Beyond placing SIMU in the engulfment pathway with Draper, the new work also suggests a role for Draper that is independent of direct corpse recognition and internalization. Like its C. elegans ortholog, Drosophila Draper interacts with a cytoplasmic adaptor protein, dCED-6, to promote apoptotic cell removal, although the precise ligand and mechanism for apoptotic cell recognition is unknown. Kurant et al. observed that Draper-deficient glia appeared to touch and presumably engulf apoptotic neurons but showed a perplexing deficiency in postengulfment corpse degradation. Meanwhile, SIMU-deficient glia failed to efficiently recognize and contact apoptotic neurons and had few internalized corpses. Furthermore, the loss of both SIMU and Draper in glia led to a phenotype similar to that of the SIMU-only fly mutant where there was a defect in apoptotic neuron recognition and contact. Kurant et al. thus propose that Draper functions primarily in corpse degradation rather than recognition, which instead is performed by SIMU, the corpse recognition/tethering receptor. This is a provocative notion in light of previous work showing Draper localization at dying neurons and a requirement for Draper expression in glia in order for them to move toward injured axons (Awasaki et al., 2006; MacDonald et al., 2006) . But how can one reconcile this with the data of Kurant et al. suggesting a role for Draper only after internalization of dying cells? The answer may lie in the unique properties of SIMU. It is possible that SIMU may function upstream of multiple engulfment receptors, with Draper being one of them. Indeed, there are multiple engulfment receptors in mammals that act alone or in combination. Similarly, there are two redundant pathways in C. elegans, with CED-1 (the Draper ortholog) providing the receptor in one pathway, and an unknown receptor upstream of the cytoplasmic CED-12/ CED-5/CED-2 module in the other. If the multiple-receptor model can be extended to Drosophila, then Draperdeficient flies can still show engulfment through other receptors but cannot fully overcome the critical requirement for Draper in corpse degradation, hence the observed phenotype.
The engulfment pathways of model organisms are fascinatingly complex with many more pieces of the puzzle yet to be discovered. The Kurant et al. study identifying SIMU as a new player in the engulfment of apoptotic cells in the fly CNS provides tantalizing possibilities for understanding this fundamentally important problem of apoptotic cell clearance.
In eukaryotic cells, gene activity is controlled not only by DNA sequences but also by epigenetic marks, which can be transmitted to a cell's progeny during mitosis or meiosis. Although epigenetic regulation is generally mediated by histone modifications, histone variants, and DNA cytosine methylation, it also involves the production and action of noncoding RNAs, particularly small RNAs (Bernstein et al., 2007; Huettel et al., 2006; Henderson and Jacobsen, 2007 ). An essential step in understanding epigenetic regulation is to have genomewide, high-resolution maps of these epigenetic features. Just as the study of genetics has been revolutionized by the ability to sequence entire eukaryotic genomes, next-generation sequencing technologies are now making it possible to determine the genome-wide distributions of methylated DNA, histone variants, and histone modifications. In short, epigenomes can now be sequenced. In this issue, Ecker and colleagues (Lister et al., 2008 ) present a genome-wide map of DNA methylation at single-base resolution in developing floral tissue of the model plant Arabidopsis. Integrating this map with an analysis of the floral transcriptome and small RNA profiles reveals new insights into the global interplay of DNA methylation, small RNAs, and transcription.
Lister and colleagues used bisulfite sequencing to determine the methylome of Arabidopsis floral tissues. In a complementary paper in Nature, Jacobsen and coworkers (Cokus et al., 2008) independently used the same technology to sequence the methylome of adult Arabidopsis plants. Like previous studies that mapped methylation in Arabidopsis using microarrays (Zhang et al., 2006; Zilberman et al., 2007) , these new studies find extensive DNA methylation throughout the genome. They show that methylation is high in heterochromatic regions, dispersed in euchromatic regions, and prevalent in the body of genes. The mapping of DNA methylation at single-base resolution also reveals that local sequence context has a strong effect on cytosine methylation. The results have important implications for clarifying the mechanisms of action and characteristics of DNA methyltransferase enzymes, and also contribute to a better understanding of the evolution of gene promoters and other regulatory sequences.
Both of the new studies compared the methylomes of wild-type plants to those of plants lacking individual DNA methyltransferases (DNMTs). De novo methylation in Arabidopsis is carried out by the methyltransferases DRM1 and DRM2, which are orthologs of the DNMT3 family in mammals. In contrast, maintenance of CG and CHG (where H is C, T, or A) methylation is mediated by the DNMT1-like enzyme MET1 and the plant-specific enzyme CMT3, respectively (Henderson and Jacobsen, 2007) . Because it is presumed that asymmetric CHH methylation cannot be maintained during DNA replication (Huettel et al., 2006) , the de novo methyltransferases DRM1 and DRM2 are expected to be the main (or sole) enzymes responsible for CHH methylation. The new studies, however, show that met1 and cmt3 loss-of-function mutations have even greater effects in reducing the overall level of CHH methylation in the genome than does the loss of both drm1 and drm2. This result suggests that MET1 and CMT3 may also be important for de novo methylation at many genomic regions (Figure 1 ). In addition, maintenance of methylation at CG and CHG sites may be required for efficient CHH methylation by DRM1 and DRM2.
Lister et al. also sequenced the transcriptome of Arabidopsis floral tissues, including an extensive analysis of small RNA populations. Comparing epigenome Sequencing Comes of Age Jian-Kang Zhu 1, *
